Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | December 11, 2017 |
| Target | Hookipa |
| Sector | Life Science |
| Investor(s) | HBM Partners |
| Deal Type | Venture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| Deal Context for Investor | # |
|---|---|
| Overall | 18 of 66 |
| Sector: Life Science | 14 of 56 |
| Type: Venture | 12 of 52 |
| State: New York | 1 of 1 |
| Country: United States | 13 of 44 |
| Year: 2017 | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-02 |
Allena Pharmaceuticals
Newton, Massachusetts, United States Allena Pharmaceuticals is a clinical biopharma company developing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena Pharmaceuticals was founded in 2011 and is based in Newton, Massachussetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-05-22 |
Sublimity Therapeutics
Dublin, Ireland Sublimity Therapeutics is a specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and immunological diseases. Sublimity Therapeutics was founded in 2003 and is based in Dublin, Ireland. |
Buy | - |
